Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13797928 | 1.00 | CA14 (0.45) | CA14CA12SMN1; SMN2TSHRCA7 | |
| SCHEMBL8164724 | 1.00 | CA14 (0.45) | CA14CA12SMN1; SMN2TSHRCA7 | |
| SCHEMBL9925882 | 1.00 | CA14 (0.45) | CA14CA12SMN1; SMN2TSHRCA7 | |
| SCHEMBL24556376 | 1.00 | CA14 (0.45) | CA14CA12SMN1; SMN2TSHRCA7 | |
| SCHEMBL13204470 | 0.82 | CA14 (0.58) | CA14CA12SMN1; SMN2TSHRCA7 | |
| SCHEMBL6966533 | 0.82 | CA14 (0.58) | CA14CA12SMN1; SMN2TSHRCA7 | |
| SCHEMBL7274381 | 0.82 | CA14 (0.58) | CA14CA12SMN1; SMN2TSHRCA7 | |
| Hydrochloric Acid SCHEMBL1761465 | 0.80 | CA14 (0.56) | CA14CA12SMN1; SMN2TSHRCA7 | |
| Hydrochloric Acid SCHEMBL17559741 | 0.80 | CA14 (0.56) | CA14CA12SMN1; SMN2TSHRCA7 | |
| Hydrochloric Acid SCHEMBL29398016 | 0.80 | CA14 (0.56) | CA14CA12SMN1; SMN2TSHRCA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331685-A1 | HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF | AG PLENUS LTD (IL) | 2023-10-19 | — | — | US | disclosed |
| EP-3502120-B1 | PANAXDIOL-TYPE GINSENOSIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | UNIV ARMY MEDICAL (CN) | 2022-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331685-A1 | HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF | DDT, HDHD5, HPD | CA14 1985/4885CA12 1924/4885SMN1; SMN2 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.